ATAI
low doses enhanced learning and memory significantly reverses memory deficits memory challenged young dogs phase scopolamine memory challenge clinical and non clinical studies provide consistent evidence of pro cognitive effect along inverted bell shaped dose response curve learnings in reversed in | ATAI
Company
Deck Type
Sector
Industry
Deck date
March 2023
Slide
11 of 31
Similar slides by ATAI
See diffirences between slides (animation)
Investor Presentation
April 2023
scopolamine challenge in dogs scopolamine challenge in volunteers phase shows a consistent inverted shaped response curve across preclinical and clinical studies learning and memory a | ATAI
Related slides by other companies
BioNTech
Results
November 2020
oncology pipeline expanded to product candidates in clinical trials | BioNTech
Genelux
Investor Presentation
February 2024
systemic administration demonstrated dose dependent benefit | Genelux
Ocuphire Pharma
Investor Day
January 2022
phase clinical trials data supporting the zeta trial rat aches high levels in rat eye is orally | Ocuphire Pharma
GH Research
Investor Presentation
November 2023
design of phase clinical pharmacology trial in healthy volunteers | GH Research
Other recent decks by ATAI
See all presentations (13 decks)
Investor Presentation
January 2024
Investor Presentation
October 2023
Investor Conference
May 2023
Investor Presentation
April 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io